# Hormone Replacement Therapy Domain - Plan

## Vision

Apply Domain-Driven Design principles to model hormone replacement therapy systems, capturing the clinical workflows, protocol management, laboratory monitoring, side effect tracking, treatment optimization, and outcomes measurement that constitute comprehensive HRT care.

## Goals

1. Establish a ubiquitous language that bridges clinical endocrinology, pharmacy, and patient care terminology.
2. Define bounded contexts that reflect the natural divisions within HRT clinical practice.
3. Model aggregates, entities, and value objects that accurately represent hormone therapy domain concepts.
4. Document domain events that drive cross-context communication and clinical workflows.
5. Capture integration patterns between bounded contexts such as clinical assessment informing protocol selection.
6. Address regulatory compliance including FDA guidelines, state pharmacy boards, and clinical standards of care.

## Bounded Contexts

### Clinical Assessment Context

Responsible for initial patient evaluation, symptom scoring, hormone panel interpretation, and candidacy determination. This context owns the patient intake workflow and produces clinical assessment aggregates that inform protocol selection.

### Hormone Protocol Context

Manages HRT regimen definitions, delivery method specifications, dosing schedules, and prescription generation. This context translates clinical assessments into actionable treatment protocols, maintaining a catalog of approved formulations and their clinical parameters.

### Lab Monitoring Context

Handles laboratory test ordering, result interpretation, trend analysis, and threshold alerting. This context consumes treatment protocol data to determine monitoring schedules and evaluates lab results against therapeutic targets.

### Side Effect Management Context

Tracks adverse events, manages contraindication databases, performs risk stratification, and coordinates mitigation strategies. This context receives signals from lab monitoring and clinical assessment to identify and respond to treatment-related complications.

### Treatment Optimization Context

Performs dose titration calculations, formulation adjustments, and combination therapy planning. This context synthesizes data from lab monitoring, side effect management, and outcomes tracking to recommend protocol modifications.

### Outcomes Tracking Context

Measures symptom resolution rates, quality of life scores, long-term health outcomes, and treatment efficacy. This context aggregates longitudinal data to evaluate treatment success and inform evidence-based practice improvements.

## Phases

### Phase 1: Foundation

- Define ubiquitous language across all bounded contexts.
- Establish strategic design patterns including context map and subdomain classification.
- Document anti-corruption layers between contexts.

### Phase 2: Tactical Design

- Model aggregates, entities, and value objects for each bounded context.
- Define domain events and their cross-context flows.
- Specify repositories and domain services.

### Phase 3: Integration

- Document event-driven architecture patterns.
- Define integration patterns between bounded contexts.
- Address cross-cutting concerns including standards and regulatory compliance.

### Phase 4: Validation

- Review domain models against clinical workflows.
- Validate ubiquitous language with domain experts.
- Audit documentation for completeness and consistency.

## References

- Evans, Eric. Domain-Driven Design: Tackling Complexity in the Heart of Software. Addison-Wesley, 2003.
- Vernon, Vaughn. Implementing Domain-Driven Design. Addison-Wesley, 2013.
- Khononov, Vlad. Learning Domain-Driven Design. O'Reilly Media, 2021.
- The Endocrine Society. Clinical Practice Guidelines for Hormone Therapy.
- North American Menopause Society. Position Statement on Hormone Therapy.
